Key result
Pimobendan and levosimendan appear more beneficial than traditional inotropic agents, which carry risks of calcium overload, arrhythmias, and myocardial injury in acute heart failure.
Population
Patients with acute or decompensated heart failure
Design
Review
Authors
Loading...
Should not yet alter inotrope choice in acute HF; hypothesis-generating for calcium sensitizers pending RCTs.
Traditional inotropic agents carry significant risks of arrhythmias and cell death, highlighting the potential benefit of calcium sensitizers like levosimendan.
Endoh et al. (2006) conducted a review in Acute or decompensated heart failure. Inotropic agents was evaluated. Pimobendan and levosimendan appear more beneficial than traditional inotropic agents, which carry risks of calcium overload, arrhythmias, and myocardial injury in acute heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: